專利名稱：METHOD AND PHARMACEUTICAL

COMPOSITION FOR INHIBITINGPI3K/AKT/MTOR SIGNAL PATH

發(fā)明人：Duan, Lei,Levenson, Viktor,Ying, Guoguang申請?zhí)枺篍P13841191.3申請日：20130929公開號：EP2905032A1公開日：20150812

專利附圖：

摘要：The present invention relates to a pharmaceutical composition of PRCPantagonist, PREP antagonist, or PRCP-PREP dual antagonist. The present invention also

relates to a pharmaceutical composition jointly using PRCP antagonist and mTORantagonist, or jointly using PREP antagonist and mTOR antagonist, or jointly using PRCP-PREP dual antagonist and mTOR antagonist. In addition, the present invention alsorelates to a method for utilizing the pharmaceutical compositions to treat and preventcancers and diseases related to insulin receptor substrate protein and PI3K/AKT/mTORsignal pathway.

申請人：Targeted Therapeutics, LLC

地址：29 Buckingham Lane Buffalo Grove, IL 600 US

國籍：US

代理機構：Williams, Andrea

更多信息請下載全文后查看